Unmasking immune sensing of retroviruses: Interplay between innate sensors and host effectors

Cytokine and Growth Factor Reviews

Volumn 25, Issue 6, 2014, Pages 657-668

  van Montfoort, Nadine ^a   Olagnier, David ^a   Hiscott, John ^a  

^a Vaccine and Gene Therapy Institute of Florida   (United States)

Author keywords

HIV 1; Host restriction factors; HTLV 1; Innate immune sensing; Retroviruses; SAMHD1; Trex1, STING, cGAS, cGAMP, interferon

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CELL PROTEIN; CYCLOPHILIN A; GLUCOSE TRANSPORTER 1; HEPARIN SULFATE PROTEOGLYCAN; INTERFERON; NEUROPILIN 1; PATTERN RECOGNITION RECEPTOR; PROTEOGLYCAN; SAMHD1 PROTEIN; SCHLAFEN PROTEIN 11; STING PROTEIN; TETHERIN PROTEIN; TREX1 PROTEIN; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENVELOPE PROTEIN; EXODEOXYRIBONUCLEASE; IFI16 PROTEIN, HUMAN; MB21D1 PROTEIN, HUMAN; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; NUCLEAR PROTEIN; NUCLEOTIDYLTRANSFERASE; PHOSPHOPROTEIN; SAMHD1 PROTEIN, HUMAN; THREE PRIME REPAIR EXONUCLEASE 1;

APOPTOSIS; CELL DEATH; CELL FATE; DNA RNA HYBRIDIZATION; DNA SYNTHESIS; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOREGULATION; INNATE IMMUNE SENSING; INNATE IMMUNITY; LIFE CYCLE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PYROPTOSIS; RETROVIRUS INFECTION; REVIEW; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS REPLICATION; ANIMAL; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

ANIMALS; EXODEOXYRIBONUCLEASES; HIV INFECTIONS; HIV-1; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNITY, INNATE; MONOMERIC GTP-BINDING PROTEINS; NUCLEAR PROTEINS; NUCLEOTIDYLTRANSFERASES; PHOSPHOPROTEINS;

EID: 84918539112     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2014.08.006     Document Type: Review

References (141)

1. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009, 30:766-775.
2. Brennan K., Bowie A.G. Activation of host pattern recognition receptors by viruses. Curr Opin Microbiol 2010, 13:503-507.
3. Thompson M.R., Kaminski J.J., Kurt-Jones E.A., Fitzgerald K.A. Pattern recognition receptors and the innate immune response to viral infection. Viruses 2011, 3:920-940.
4. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
5. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5:730-737.
6. Ramos H.J., Gale M. RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity. Curr Opin Virol 2011, 1:167-176.
7. Dixit E., Kagan J.C. Intracellular pathogen detection by RIG-I-like receptors. Adv Immunol 2013, 117:99-125.
8. Bürckstümmer T., Baumann C., Blüml S., Dixit E., Dürnberger G., Jahn H., et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009, 10:266-272.
9. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
10. Fernandes-Alnemri T., Yu J.-W., Datta P., Wu J., Alnemri E.S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009, 458:509-513.
11. Barber G.N. Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol 2011, 23:10-20.
12. Paludan S.R., Bowie A.G. Immune sensing of DNA. Immunity 2013, 38:870-880.
13. Unterholzner L. The interferon response to intracellular DNA: why so many receptors?. Immunobiology 2013, 218:1312-1321.
14. Jakobsen M.R., Bak R.O., Andersen A., Berg R.K., Jensen S.B., Tengchuan J., et al. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc Natl Acad Sci U S A 2013, 110:E4571-E4580.
15. Monroe K.M., Yang Z., Johnson J.R., Geng X., Doitsh G., Krogan N.J., et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 2014, 343:428-432.
16. Gao D., Wu J., Wu Y.-T., Du F., Aroh C., Yan N., et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 2013, 341:903-906.
17. Douville R.N., Hiscott J. The interface between the innate interferon response and expression of host retroviral restriction factors. Cytokine 2010, 52:108-115.
18. Towers G.J., Noursadeghi M. Interactions between HIV-1 and the cell-autonomous innate immune system. Cell Host Microbe 2014, 16:10-18.
19. Hatziioannou T., Bieniasz P.D. Antiretroviral restriction factors. Curr Opin Virol 2011, 1:526-532.
20. Zheng Y.-H., Jeang K.-T., Tokunaga K. Host restriction factors in retroviral infection: promises in virus-host interaction. Retrovirology 2012, 9:112.
21. Temin H.M., Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 1970, 226:1211-1213.
22. Baltimore D. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 1970, 226:1209-1211.
23. Arrildt K.T., Joseph S.B., Swanstrom R. The HIV-1 env protein: a coat of many colors. Curr HIV/AIDS Rep 2012, 9:52-63.
24. Jones K.S., Lambert S., Bouttier M., Bénit L., Ruscetti F.W., Hermine O., et al. Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors. Viruses 2011, 3:794-810.
25. Telesnitsky A., Goff S. Reverse transcriptase and the generation of retroviral DNA. Retroviruses 1997, Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY). J. Coffin, S. Hughes, H. Varmus (Eds.).
26. Farnet C.M., Haseltine W.A. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J Virol 1991, 65:1910-1915.
27. Outline of the Integration Process. Retroviruses 1997, Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY). J. Coffin, S. Hughes, H. Varmus (Eds.).
28. Brown P.O., Bowerman B., Varmus H.E., Bishop J.M. Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein. Proc Natl Acad Sci U S A 1989, 86:2525-2529.
29. Roulston A., Lin R., Beauparlant P., Wainberg M.A., Hiscott J. Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. Microbiol Rev 1995, 59:481-505.
30. Hiscott J., Nguyen T-LA, Arguello M., Nakhaei P., Paz S. Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. Oncogene 2006, 25:6844-6867.
31. Coffin J.M., Hughes S.H., Varmus H.E. Principles of particle assembly. Retroviruses 1997, Cold Spring Harbor Laboratory Press, Retrovirus, Cold Spring Harbor (NY). J. Coffin, S. Hughes, H. Varmus (Eds.).
32. Sundquist W.I., Kräusslich H.-G. HIV-1 assembly, budding, and maturation. Cold Spring Harb Perspect Med 2012, 2:a006924.
33. Neil S., Bieniasz P. Human immunodeficiency virus, restriction factors, and interferon. J Interferon Cytokine Res 2009, 29:569-580.
34. Strebel K. HIV accessory proteins versus host restriction factors. Curr Opin Virol 2013, 3:692-699.
35. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650.
36. Chiu Y.-L., Greene W.C. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 2008, 26:317-353.
37. Koning F.A., Newman E.N.C., Kim E.-Y., Kunstman K.J., Wolinsky S.M., Malim M.H. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol 2009, 83:9474-9485.
38. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424:99-103.
39. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., et al. DNA deamination mediates innate immunity to retroviral infection. Cell 2003, 113:803-809.
40. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003, 424:94-98.
41. Krisko J.F., Martinez-Torres F., Foster J.L., Garcia J.V. HIV restriction by APOBEC3 in humanized mice. PLoS Pathog 2013, 9:e1003242.
42. Mariani R., Chen D., Schröfelbauer B., Navarro F., König R., Bollman B., et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 2003, 114:21-31.
43. Derse D., Hill S.A., Princler G., Lloyd P., Heidecker G. Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid. Proc Natl Acad Sci U S A 2007, 104:2915-2920.
44. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
45. Yap M.W., Nisole S., Lynch C., Stoye J.P. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 2004, 101:10786-10791.
46. Hatziioannou T., Perez-Caballero D., Yang A., Cowan S., Bieniasz P.D. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci U S A 2004, 101:10774-10779.
47. Grütter M.G., Luban J. TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling. Curr Opin Virol 2012, 2:142-150.
48. Javanbakht H., Diaz-Griffero F., Stremlau M., Si Z., Sodroski J. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha. J Biol Chem 2005, 280:26933-26940.
49. Kutluay S.B., Perez-Caballero D., Bieniasz P.D. Fates of retroviral core components during unrestricted and TRIM5-restricted infection. PLoS Pathog 2013, 9:e1003214.
50. Sokolskaja E., Luban J. Cyclophilin, TRIM5, and innate immunity to HIV-1. Curr Opin Microbiol 2006, 9:404-408.
51. Battivelli E., Lecossier D., Matsuoka S., Migraine J., Clavel F., Hance A.J. Strain-specific differences in the impact of human TRIM5alpha, different TRIM5alpha alleles, and the inhibition of capsid-cyclophilin A interactions on the infectivity of HIV-1. J Virol 2010, 84:11010-11019.
52. Goldstone D.C., Ennis-Adeniran V., Hedden J.J., Groom H.C.T., Rice G.I., Christodoulou E., et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 2011, 480:379-382.
53. Powell R.D., Holland P.J., Hollis T., Perrino F.W. Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J Biol Chem 2011, 286:43596-43600.
54. Hrecka K., Hao C., Gierszewska M., Swanson S.K., Kesik-Brodacka M., Srivastava S., et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474:658-661.
55. Laguette N., Sobhian B., Casartelli N., Ringeard M., Chable-Bessia C., Ségéral E., et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474:654-657.
56. Puigdomènech I., Casartelli N., Porrot F., Schwartz O. SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells. J Virol 2013, 87:2846-2856.
57. Srivastava S., Swanson S.K., Manel N., Florens L., Washburn M.P., Skowronski J. Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog 2008, 4:e1000059.
58. Sharova N., Wu Y., Zhu X., Stranska R., Kaushik R., Sharkey M., et al. Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog 2008, 4:e1000057.
59. Goujon C., Rivière L., Jarrosson-Wuilleme L., Bernaud J., Rigal D., Darlix J.-L., et al. SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology 2007, 4:2.
60. Schaller T., Bauby H., Hué S., Malim M.H., Goujon C. New insights into an X-traordinary viral protein. Front Microbiol 2014, 5:126.
61. Baldauf H.-M., Pan X., Erikson E., Schmidt S., Daddacha W., Burggraf M., et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med 2012, 18:1682-1687.
62. Descours B., Cribier A., Chable-Bessia C., Ayinde D., Rice G., Crow Y., et al. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology 2012, 9:87.
63. Cribier A., Descours B., Valadão A.L.C., Laguette N., Benkirane M. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep 2013, 3:1036-1043.
64. White T.E., Brandariz-Nuñez A., Valle-Casuso J.C., Amie S., Nguyen L., Kim B., et al. Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1. Virology 2013, 436:81-90.
65. Beloglazova N., Flick R., Tchigvintsev A., Brown G., Popovic A., Nocek B., et al. Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction. J Biol Chem 2013, 288:8101-8110.
66. Sze A., Olagnier D., Lin R., van Grevenynghe J., Hiscott J. SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection. J Mol Biol 2013, 425:4981-4994.
67. Lahouassa H., Daddacha W., Hofmann H., Ayinde D., Logue E.C., Dragin L., et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012, 13:223-228.
68. St Gelais C., de Silva S., Amie S.M., Coleman C.M., Hoy H., Hollenbaugh Ja, et al. SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons. Retrovirology 2012, 9:105.
69. Yang Z., Greene W.C. A new activity for SAMHD1 in HIV restriction. Nat Med 2014, 20:808-809.
70. White T.E., Brandariz-Nuñez A., Valle-Casuso J.C., Amie S., Nguyen L.A., Kim B., et al. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe 2013, 13:441-451.
71. Welbourn S., Dutta S.M., Semmes O.J., Strebel K. Restriction of virus infection but not catalytic dNTPase activity is regulated by phosphorylation of SAMHD1. J Virol 2013, 87:11516-11524.
72. Ryoo J., Choi J., Oh C., Kim S., Seo M., Kim S.-Y., et al. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat Med 2014, 20:936-941.
73. Gramberg T., Kahle T., Bloch N., Wittmann S., Müllers E., Daddacha W., et al. Restriction of diverse retroviruses by SAMHD1. Retrovirology 2013, 10:26.
74. Sze A., Belgnaoui S.M., Olagnier D., Lin R., Hiscott J., van Grevenynghe J. Host restriction factor SAMHD1 limits human T cell leukemia virus type 1 infection of monocytes via STING-mediated apoptosis. Cell Host Microbe 2013, 14:422-434.
75. Jones K.S., Petrow-Sadowski C., Huang Y.K., Bertolette D.C., Ruscetti F.W. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat Med 2008, 14:429-436.
76. Hollenbaugh J.a., Gee P., Baker J., Daly M.B., Amie S.M., Tate J., et al. Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells. PLoS Pathog 2013, 9:e1003481.
77. Neil S.J.D., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
78. Van Damme N., Goff D., Katsura C., Jorgenson R.L., Mitchell R., Johnson M.C., et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252.
79. Perez-Caballero D., Zang T., Ebrahimi A., McNatt M.W., Gregory D.A., Johnson M.C., et al. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 2009, 139:499-511.
80. Pais-Correia A.-M., Sachse M., Guadagnini S., Robbiati V., Lasserre R., Gessain A., et al. Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat Med 2010, 16:83-89.
81. Li M., Kao E., Gao X., Sandig H., Limmer K., Pavon-Eternod M., et al. Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature 2012, 491:125-128.
82. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C.T., Sodroski J., et al. Functional association of cyclophilin A with HIV-1 virions. Nature 1994, 372:363-365.
83. Franke E.K., Yuan H.E., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994, 372:359-362.
84. Sokolskaja E., Sayah D.M., Luban J. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. J Virol 2004, 78:12800-12808.
85. Hatziioannou T., Perez-Caballero D., Cowan S., Bieniasz P.D. Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J Virol 2005, 79:176-183.
86. Towers G.J., Hatziioannou T., Cowan S., Goff S.P., Luban J., Bieniasz P.D. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med 2003, 9:1138-1143.
87. Schaller T., Ocwieja K.E., Rasaiyaah J., Price A.J., Brady T.L., Roth S.L., et al. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog 2011, 7:e1002439.
88. Price A.J., Fletcher A.J., Schaller T., Elliott T., Lee K., KewalRamani V.N., et al. CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog 2012, 8:e1002896.
89. Rasaiyaah J., Tan C.P., Fletcher A.J., Price A.J., Blondeau C., Hilditch L., et al. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 2013, 503:402-405.
90. Fan Z., Beresford P.J., Oh D.Y., Zhang D., Lieberman J. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003, 112:659-672.
91. Lieberman J., Fan Z. Nuclear war: the granzyme A-bomb. Curr Opin Immunol 2003, 15:553-559.
92. Chowdhury D., Beresford P.J., Zhu P., Zhang D., Sung J.-S., Demple B., et al. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol Cell 2006, 23:133-142.
93. Yan N., Cherepanov P., Daigle J.E., Engelman A., Lieberman J. The SET complex acts as a barrier to autointegration of HIV-1. PLoS Pathog 2009, 5:e1000327.
94. Yan N., Regalado-Magdos A.D., Stiggelbout B., Lee-Kirsch M.A., Lieberman J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol 2010, 11:1005-1013.
95. Hasan M., Yan N. Safeguard against DNA sensing: the role of TREX1 in HIV-1 infection and autoimmune diseases. Front Microbiol 2014, 5:193.
96. Mazur D.J., Perrino F.W. Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3'-->5' exonucleases. J Biol Chem 1999, 274:19655-19660.
97. Mazur D.J., Perrino F.W. Excision of 3' termini by the Trex1 and TREX2 3'-->5' exonucleases. Characterization of the recombinant proteins. J Biol Chem 2001, 276:17022-17029.
98. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
99. Crow Y.J., Hayward B.E., Parmar R., Robins P., Leitch A., Ali M., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet 2006, 38:917-920.
100. Iwasaki A. Innate immune recognition of HIV-1. Immunity 2012, 37:389-398.
101. Wu J., Chen Z.J. Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol 2014, 32:461-488.
102. Nazli A., Kafka J.K., Ferreira V.H., Anipindi V., Mueller K., Osborne B.J., et al. HIV-1 gp120 induces TLR2- and TLR4-mediated innate immune activation in human female genital epithelium. J Immunol 2013, 191:4246-4258.
103. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
104. Fonteneau J.-F., Larsson M., Beignon A.-S., McKenna K., Dasilva I., Amara A., et al. Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol 2004, 78:5223-5232.
105. Kane M., Case L.K., Wang C., Yurkovetskiy L., Dikiy S., Golovkina T.V. Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry. Immunity 2011, 35:135-145.
106. Cervantes J.L., Weinerman B., Basole C., Salazar J.C. TLR8: the forgotten relative revindicated. Cell Mol Immunol 2012, 9:434-438.
107. Beignon A.-S., McKenna K., Skoberne M., Manches O., DaSilva I., Kavanagh D.G., et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005, 115:3265-3275.
108. Meier A., Chang J.J., Chan E.S., Pollard R.B., Sidhu H.K., Kulkarni S., et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 2009, 15:955-959.
109. Colisson R., Barblu L., Gras C., Raynaud F., Hadj-Slimane R., Pique C., et al. Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells. Blood 2010, 115:2177-2185.
110. Chang J., Lindsay R.J., Kulkarni S., Lifson J.D., Carrington M., Altfeld M. Polymorphisms in interferon regulatory factor 7 reduce interferon-α responses of plasmacytoid dendritic cells to HIV-1. AIDS 2011, 25:715-717.
111. Meier A., Alter G., Frahm N., Sidhu H., Li B., Bagchi A., et al. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 2007, 81:8180-8191.
112. Chattergoon M.A., Latanich R., Quinn J., Winter M.E., Buckheit R.W., Blankson J.N., et al. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal toll-like receptors without induction of Type 1 interferon. PLoS Pathog 2014, 10:e1004082.
113. Guo H., Gao J., Taxman D.J., Ting J.P.Y., Su L. HIV-1 infection induces IL-1β production via TLR8-dependent and NLRP3-inflammasome mechanisms in human monocytes. J Biol Chem 2014, 289:21716-21726.
114. Gringhuis S.I., van der Vlist M., van den Berg L.M., den Dunnen J., Litjens M., Geijtenbeek T.B.H. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat Immunol 2010, 11:419-426.
115. Lambert A.A., Barabé F., Gilbert C., Tremblay M.J. DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway. Blood 2011, 117:6589-6599.
116. Van der Vlist M., van der Aar A.M.G., Gringhuis S.I., Geijtenbeek T.B.H. Innate signaling in HIV-1 infection of dendritic cells. Curr Opin HIV AIDS 2011, 6:348-352.
117. Luban J. Innate immune sensing of HIV-1 by dendritic cells. Cell Host Microbe 2012, 12:408-418.
118. Ishikawa H., Barber G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455:674-678.
119. Ishikawa H., Ma Z., Barber G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461:788-792.
120. Abe T., Harashima A., Xia T., Konno H., Konno K., Morales A., et al. STING recognition of cytoplasmic DNA instigates cellular defense. Mol Cell 2013, 50:5-15.
121. Sun L., Wu J., Du F., Chen X., Chen Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339:786-791.
122. Wu J., Sun L., Chen X., Du F., Shi H., Chen C., et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013, 339:826-830.
123. Ablasser A., Goldeck M., Cavlar T., Deimling T., Witte G., Röhl I., et al. cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature 2013, 498:380-384.
124. Solis M., Nakhaei P., Jalalirad M., Lacoste J., Douville R., Arguello M., et al. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. J Virol 2011, 85:1224-1236.
125. Berg R.K., Melchjorsen J., Rintahaka J., Diget E., Søby S., Horan K.A., et al. Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA. PLoS One 2012, 7:e29291.
126. Pertel T., Hausmann S., Morger D., Züger S., Guerra J., Lascano J., et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472:361-365.
127. Tareen S.U., Emerman M. Trim5 TAKes on pattern recognition. Cell Host Microbe 2011, 9:349-350.
128. Manel N., Hogstad B., Wang Y., Levy D.E., Unutmaz D., Littman D.R. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 2010, 467:214-217.
129. Lahaye X., Satoh T., Gentili M., Cerboni S., Conrad C., Hurbain I., et al. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 2013, 39:1132-1142.
130. Galão R.P., Le Tortorec A., Pickering S., Kueck T., Neil S.J.D. Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses. Cell Host Microbe 2012, 12:633-644.
131. Hotter D., Sauter D., Kirchhoff F. Emerging role of the host restriction factor tetherin in viral immune sensing. J Mol Biol 2013, 425:4956-4964.
132. Doitsh G., Cavrois M., Lassen K.G., Zepeda O., Yang Z., Santiago M.L., et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 2010, 143:789-801.
133. Doitsh G., Galloway N.L.K., Geng X., Yang Z., Monroe K.M., Zepeda O., et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014, 505:509-514.
134. Cooper A., García M., Petrovas C., Yamamoto T., Koup R.A., Nabel G.J. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature 2013, 498:376-379.
135. Cox A.L., Siliciano R.F. HIV: Not-so-innocent bystanders. Nature 2014, 505:492-493.
136. Gaiha G.D., Brass A.L. Immunology. The fiery side of HIV-induced T cell death. Science 2014, 343:383-384.
137. Yan N., Lieberman J. Gaining a foothold: how HIV avoids innate immune recognition. Curr Opin Immunol 2011, 23:21-28.
138. Gehrke N., Mertens C., Zillinger T., Wenzel J., Bald T., Zahn S., et al. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity 2013, 39:482-495.
139. Rehwinkel J. Mouse knockout models for HIV-1 restriction factors. Cell Mol Life Sci 2014.
140. Ablasser A., Hemmerling I., Schmid-Burgk J.L., Behrendt R., Roers A., Hornung V. TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner. J Immunol 2014, 192:5993-5997.
141. Laguette N., Brégnard C., Hue P., Basbous J., Yatim A., Larroque M., et al. Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell 2014, 156:134-145.